Kana Tsuchimoto

Statistics

Publications

Citations

169

H-Index

Active since

2021

Affiliations

National Institute of Infectious Diseases(Current)

Tokyo University of Science

Kyoto University

Pukyong National University

Japan Science and Technology Agency

Kana Tsuchimoto is an author at National Institute of Infectious Diseases specializing in antiviral therapy, antiviral pharmacology, and infectious diseases.

Publications per year

2021–2023

Publications

Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2

Wakana Saso, Masako Yamasaki, Shin‐ichi Nakakita et al. · PLoS Pathogens · 2022 · 39 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa et al. · Antiviral Research · 2022 · 33 citations · Full text

Pharmacy, Immunology, Infectious Diseases +16

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments

Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki et al. · The Journal of Infectious Diseases · 2023 · 28 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro

Hirofumi Ohashi, Feng Wang, Frank Stappenbeck et al. · International Journal of Molecular Sciences · 2021 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents

Takayuki Hishiki, Takeshi Morita, Daisuke Akazawa et al. · Microbiology Spectrum · 2023 · 18 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

1–5 of 7